|
|
| | SALUSIN-ALPHA (HUMAN) Basic information |
| Product Name: | SALUSIN-ALPHA (HUMAN) | | Synonyms: | Salusin-a (huMan);SGALPPAPAAPRPALRAQRAGPAGPGAK-NH2;SER-GLY-ALA-LEU-PRO-PRO-ALA-PRO-ALA-ALA-PRO-ARG-PRO-ALA-LEU-ARG-ALA-GLN-ARG-ALA-GLY-PRO-ALA-GLY-PRO-GLY-ALA-LYS-NH2;SALUSIN-ALPHA;SALUSIN-ALPHA (HUMAN);H-SER-GLY-ALA-LEU-PRO-PRO-ALA-PRO-ALA-ALA-PRO-ARG-PRO-ALA-LEU-ARG-ALA-GLN-ARG-ALA-GLY-PRO-ALA-GLY-PRO-GLY-ALA-LYS-NH2;L-Lysinamide, L-serylglycyl-L-alanyl-L-leucyl-L-prolyl-L-prolyl-L-alanyl-L-prolyl-L-alanyl-L-alanyl-L-prolyl-L-arginyl-L-prolyl-L-alanyl-L-leucyl-L-arginyl-L-alanyl-L-glutaminyl-L-arginyl-L-alanylglycyl-L-prolyl-L-alanylglycyl-L-prolylglycyl-L-alanyl-;Salusin α(human) | | CAS: | 624735-22-4 | | MF: | C114H192N40O30 | | MW: | 2602.99 | | EINECS: | | | Product Categories: | | | Mol File: | 624735-22-4.mol |  |
| | SALUSIN-ALPHA (HUMAN) Chemical Properties |
| Sequence | Ser-Gly-Ala-Leu-Pro-Pro-Ala-Pro-Ala-Ala-Pro-Arg-Pro-Ala-Leu-Arg-Ala-Gln-Arg-Ala-Gly-Pro-Ala-Gly-Pro-Gly-Ala-Lys-NH2 |
| | SALUSIN-ALPHA (HUMAN) Usage And Synthesis |
| Uses | Salusin-α is an endogenous bioactive peptide with hemodynamic and cell proliferation activities. Salusin-α can stimulate the proliferation of quiescent vascular smooth muscle cells (VSMCs) and fibroblasts, leading to a rapid and significant decrease in blood pressure and heart rate, but its effect is weaker than that of Salusin-β (HY-P10617). Salusin-α has potential application value in cardiovascular disease research[1]. | | References | [1] Shichiri, et al. "Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities." Nature medicine 9.9 (2003): 1166-1172. DOI:10.1038/nm913 |
| | SALUSIN-ALPHA (HUMAN) Preparation Products And Raw materials |
|